Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 78Myelodysplastic Syndromes 75Precursor Cell Lymphoblastic Leukemia-Lymphoma 70Leukemia, Lymphocytic, Chronic, B-Cell 58Leukemia 55Hodgkin Disease 55Lymphoma, Non-Hodgkin 54Lymphoma 48Multiple Myeloma 45Myeloproliferative Disorders 41Lymphoma, Follicular 40Graft vs Host Disease 38Lymphoma, Mantle-Cell 36Lymphoma, Large B-Cell, Diffuse 36Leukemia, Myelomonocytic, Chronic 36Lymphoma, B-Cell, Marginal Zone 35Leukemia, Myeloid, Accelerated Phase 34Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33Congenital Abnormalities 33Burkitt Lymphoma 33Leukemia, Myeloid, Chronic-Phase 29Primary Myelofibrosis 28Hematologic Neoplasms 28Neoplasms, Plasma Cell 24Lymphoma, Large-Cell, Immunoblastic 24Blast Crisis 24Waldenstrom Macroglobulinemia 20Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Myelodysplastic-Myeloproliferative Diseases 18Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17

Interventions

Cytarabine 3Cyclophosphamide 3thymoglobulin 2fludarabine phosphate 2fludarabine 2Thiotepa 2Tacrolimus 2Rituximab 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2vosaroxin 1plerixafor 1devimistat 1blinatumomab 1aldesleukin 1Transplantation 1Sirolimus 1Razoxane 1Mycophenolic Acid 1Metformin 1Mesna 1Interleukin-2 1Idarubicin 1Gemtuzumab 1Dexrazoxane 1Clofarabine 1Cladribine 1Busulfan 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Sarcoma, Myeloid × Tacrolimus × Clear all
NCT02790515 2025-08-12

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
170 enrolled
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT01621477 2017-02-20

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

St. Jude Children's Research Hospital

Phase 2 Terminated
34 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡